Octane Orthobiologics, a division of Octane Medical Group, will receive money from Queen’s Park today to open six new, full-time technical and manufacturing set-up positions in Kingston.
The division will increase its staff of 11 by about 50%, CEO Tim Smith said, adding that the jobs will help the local manufacturer of bioactive medical products launch a new line of orthopedic implants.
“We will be expanding our technical team to develop and finalize and launch these products,” he said.
The company will recruit locally but also hopes to attract specialists from elsewhere into the area.
Since its incorporation in 2007, Octane has been involved in the research and development of new spinal implants for people with degenerative disc disease.
The company has three divisions: Octane Orthobiologics, Octane Biotech, which looks at tissue engineering, and Octane OEM, which handles medical product manufacturing.
